Drug Discovery · San Francisco, CA · Founded 2018 · Privately Held (backing)
Developer of a gene therapy discovery platform designed to improve research for complex diseases related to aging. Gordian Biotechnology is based in San Francisco, CA and was founded in 2018. It was valued at $170 million at its early-stage round in Dec 2021, the last priced event on record. It has raised $60 million across 1 recorded round; the latest was a $1.5 million seed round in Apr 2020.
PMV mark · valuation
$170.0M
Oct 2026
Priced at
its early-stage round
Dec 2021
Total raised
$60.0M
Last round
Seed Round
Apr 2020
Cap table — not yet on record
Gordian Biotechnology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Gordian Biotechnology with a free account
·The complete investor list: 32 names
·Watch Gordian Biotechnology: the Monday email on marks, rounds and moves
Where does Gordian Biotechnology's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Gordian Biotechnology's 1 recorded funding rounds.
